Xellar

Developer of an AI-based computational platform for drug discovery

placeCambridge, Massachusetts, United States calendar_todayFounded 2022 groups12 employees language xellarbio.com

Innovation

2 patent families — focus: Physics & computing, Chemistry & metallurgy; filing pace active. Cited 26 times.

YearFilings
20241
20251

Social engagement

Social engagement: 4.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Zhen Fund, Legend Capital.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

9 Apr 2026 · AI BIO · Greater Boston

Based on job postings tracked across public sources.

Recent activity

16 Jun 2026
Event
Microfluidics Consortium Open Day Meeting
15 May 2026
Event
MPS World Summit
19 Apr 2026
Event
AACR
Coming soon